Luteoloside attenuates neuroinflammation in focal cerebral ischemia in rats via regulation of the PPARγ/Nrf2/NF-κB signaling pathway

Rordorf, 1998, Regional ischemia and ischemic injury in patients with acute middle cerebral artery stroke as defined by early diffusion-weighted and perfusion-weighted MRI, Stroke, 29, 939, 10.1161/01.STR.29.5.939 Valen, 2004, Signal transduction through nuclear factor kappa B in ischemia-reperfusion and heart failure, Basic Res. Cardiol., 99, 1, 10.1007/s00395-003-0442-7 Anusha, 2017, Protective role of apigenin on rotenone induced rat model of Parkinson's disease: suppression of neuroinflammation and oxidative stress mediated apoptosis, Chem. Biol. Interact., 269, 67, 10.1016/j.cbi.2017.03.016 Qi, 2012, Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-κB signaling pathways, Int. Immunopharmacol., 12, 278, 10.1016/j.intimp.2011.12.001 Umesalma, 2010, Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-κB, iNOS, COX-2, TNF-α, and IL-6 in 1,2‑dimethylhydrazine-induced rat colon carcinogenesis, Basic Clin. Pharmacol. Toxicol., 107, 650, 10.1111/j.1742-7843.2010.00565.x Won, 2006, Gigantol isolated from the whole plants of Cymbidium goeringii inhibits the LPS-induced iNOS and COX-2 expression via NF-κB inactivation in RAW 264.7 macrophages cells, Planta Med., 72, 1181, 10.1055/s-2006-947201 Shi, 2014, Propofol reduces inflammatory reaction and ischemic brain damage in cerebral ischemia in rats, Neurochem. Res., 39, 793, 10.1007/s11064-014-1272-8 Shao, 2015, Neuroinflammation and neuronal autophagic death were suppressed via rosiglitazone treatment: new evidence on neuroprotection in a rat model of global cerebral ischemia, J. Neurol. Sci., 349, 65, 10.1016/j.jns.2014.12.027 Barbiero, 2014, PPAR-α agonist fenofibrate protects against the damaging effects of MPTP in a rat model of Parkinson's disease, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 53, 35, 10.1016/j.pnpbp.2014.02.009 Sauer, 2015, Ligands for the nuclear peroxisome proliferator-activated receptor gamma, Trends Pharmacol. Sci., 36, 688, 10.1016/j.tips.2015.06.010 Ricote, 2007, PPARs and molecular mechanisms of transrepression, BBA-Mol. Cell Biol. L., 1771, 926, 10.1016/j.bbalip.2007.02.013 Pedruzzi, 2012, Nrf2-keap1 system versus NF-κB: the good and the evil in chronic kidney disease?, Biochimie, 94, 2461, 10.1016/j.biochi.2012.07.015 Kim, 2010, A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders, Mutat. Res. Fundam. Mol. Mech. Mutagen., 690, 12, 10.1016/j.mrfmmm.2009.09.007 Song, 2014, Luteolin and luteolin‑7‑O‑glucoside strengthen antioxidative potential through the modulation of Nrf2/MAPK mediated HO-1 signaling cascade in RAW 264.7 cells, Food Chem. Toxicol., 65, 70, 10.1016/j.fct.2013.12.017 Qiu, 2013, HPLC-ESI-MS/MS analysis and pharmacokinetics of luteoloside, a potential anticarcinogenic component isolated from Lonicera japonica, in beagle dogs, Biomed. Chromatogr., 27, 311 Wang, 2018, Luteoloside protects the uterus from Staphylococcus aureus - induced inflammation, apoptosis, and Injury, Inflammation, 1 Xiong, 2013, Screening and identification of the antibacterial bioactive compounds from Lonicera japonica Thunb. leaves, Food Chem., 138, 327, 10.1016/j.foodchem.2012.10.127 Yao, 2015, Protection of luteolin‑7‑O‑glucoside against doxorubicin-induced injury through PTEN/Akt and ERK pathway in H9c2 cells, Cardiovasc. Toxicol., 16, 101, 10.1007/s12012-015-9317-z Sun, 2011, Protective effects of cynaroside against H2O2-induced apoptosis in H9c2 cardiomyoblasts, J. Cell. Biochem., 112, 2019, 10.1002/jcb.23121 Liu, 2018, Luteoloside attenuates anoxia/reoxygenation-induced cardiomyocytes injury via mitochondrial pathway mediated by 14-3-3η protein, Phytother. Res., 32, 1126, 10.1002/ptr.6053 Du, 2012, Probucol and atorvastatin in combination protect rat brains in MCAO model: upregulating peroxiredoxin2, Foxo3a and Nrf2 expression, Neurosci. Lett., 509, 110, 10.1016/j.neulet.2011.12.054 Colbourne, 2000, Prolonged but delayed postischemic hypothermia: a long-term outcome study in the rat middle cerebral artery occlusion model, J. Cereb. Blood Flow Metab., 20, 1702, 10.1097/00004647-200012000-00009 Bederson, 1986, Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination, Stroke, 17, 472, 10.1161/01.STR.17.3.472 Pantoni, 1998, Interrater agreement on a simple neurological score in rats, Stroke, 29, 871, 10.1161/01.STR.29.4.871 Mdzinarishvili, 2007, Bilobalide prevents ischemia-induced edema formation in vitro and in vivo, Neuroscience, 144, 217, 10.1016/j.neuroscience.2006.08.037 Yi, 2007, Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage, Neurochem. Int., 50, 1014, 10.1016/j.neuint.2007.04.019 Wang, 2018, Luteoloside protects the uterus from Staphylococcus aureus - induced inflammation, apoptosis, and injury, Inflammation, 1 Sakthivel, 2013, Amentoflavone inhibits iNOS, COX-2 expression and modulates cytokine profile, NF-κB signal transduction pathways in rats with ulcerative colitis, Int. Immunopharmacol., 17, 907, 10.1016/j.intimp.2013.09.022 Zhu, 2012, Short communication: pheromonicin-SA affects mRNA expression of toll-like receptors, cytokines, and lactoferrin by Staphylococcus aureus-infected bovine mammary epithelial cells, J. Dairy Sci., 95, 759, 10.3168/jds.2011-4703 Kim, 2004, Suppressive effect of inducible nitric oxide synthase (iNOS) expression by the methanol extract of Actinodaphne lancifolia, Phytother. Res., 18, 853, 10.1002/ptr.1558 Wu, 2016, Isoliquiritigenin prevents the progression of psoriasis-like symptoms by inhibiting NF-κB and proinflammatory cytokines, J. Mol. Med., 94, 195, 10.1007/s00109-015-1338-3 Bordet, 2006, PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases, Biochem. Soc. Trans., 34, 1341, 10.1042/BST0341341 Sundararajan, 2006, PPARgamma as a therapeutic target in central nervous system diseases, Neurochem. Int., 49, 136, 10.1016/j.neuint.2006.03.020 Kawai, 2008, PPAR-γ agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-β, Lab. Investig., 89, 47, 10.1038/labinvest.2008.104 Sundararajan, 2005, PPARγ ligands reduce inflammation and infarction size in transient focal ischemia, Neuroscience, 130, 685, 10.1016/j.neuroscience.2004.10.021 Chawla, 2001, PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation, Nat. Med., 7, 48, 10.1038/83336 Lee, 2015, Corrigendum to “Dieckol enhances the expression of antioxidant and detoxifying enzymes by the activation of Nrf2–MAPK signaling pathway in HepG2 cells”, Food Chem., 174, 538, 10.1016/j.foodchem.2014.11.090 Seo, 2009, Isoalantolactone from Inula helenium caused Nrf2-mediated induction of detoxifying enzymes, J. Med. Food, 12, 1038, 10.1089/jmf.2009.0072 Lin, 2008, Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway, Biochem. Pharmacol., 76, 967, 10.1016/j.bcp.2008.07.036 Lee, 2012, 15‑Deoxy‑Δ12,14‑prostaglandin J2 modulates manganese-induced activation of the NF-κB, Nrf2, and PI3K pathways in astrocytes, Free Radic. Biol. Med., 52, 1067, 10.1016/j.freeradbiomed.2011.12.016 Kim, 2010, A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders, Mutat. Res. Fundam. Mol. Mech. Mutagen., 690, 12, 10.1016/j.mrfmmm.2009.09.007